Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemiaBritta Will, Ulrich Steidl, Thomas O. Vogler et al.|Nature Medicine|2015Cited by 128
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AMLCurtis A. Lachowiez, Daniel A. Pollyea, Richard Dillon et al.|Blood|2024Cited by 30
Targeting MDS Stem Cells with Omacetaxine and Azacitidine for Newly Diagnosed High Grade Patients: Phase 1 Trial Results and Preliminary Mechanistic StudiesBrett M. Stevens, Daniel A. Pollyea, Amanda Winters et al.|Blood|2021Cited by 0